Cargando…

Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma

There is no recognized serum biomarker to predict the recurrence of endometrial carcinoma (EC). We aimed to explore serum human epididymis protein 4 (HE4) and cancer antigen 125 (CA125) as the biomarkers to predict and monitor recurrence of type II EC. 191 patients diagnosed with type II EC were inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quan, Quan, Liao, Qianqian, Yin, Wanchun, Zhou, Shuwei, Gong, Sainan, Mu, Xiaoling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569215/ https://www.ncbi.nlm.nih.gov/pubmed/34737393 http://dx.doi.org/10.1038/s41598-021-01263-w

Ejemplares similares

The value of serum HE4 and CA125 levels for monitoring the recurrence and risk stratification of endometrial endometrioid carcinoma
por: Gong, Sainan, et al.
Publicado: (2023)

Diagnostic Value of Preoperative CA125, LDH and HE4 for Leiomyosarcoma of the Female Reproductive System
por: Zhang, Fenfen, et al.
Publicado: (2021)

The crucial value of serum ferritin in assessing high-risk factors and prognosis for patients with endometrial carcinoma
por: Liu, Jiali, et al.
Publicado: (2023)

Identification and characterization of endometrial carcinoma with tumor markers HE4 and CA125 in serum and endometrial tissue samples
por: Cuesta-Guardiola, Tatiana, et al.
Publicado: (2021)

Serum CA125 and HE4 as Biomarkers for the Detection of Endometrial Cancer and Associated High-Risk Features
por: Barr, Chloe E., et al.
Publicado: (2022)

Clinicopathologic factors associated with short-term survival in advanced epithelial ovarian cancer
por: Zhou, Shuwei, et al.
Publicado: (2019)

Urine CA125 and HE4 for the Triage of Symptomatic Women with Suspected Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2022)

Value of serum miR-21, HE4 and CA125 in surveillance for postoperative recurrent or metastatic ovarian cancer
por: Gong, Zhenying, et al.
Publicado: (2022)

Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2021)

Analysis of serum level of HE4 and CA125 considering selected risk factors among patients with endometrioid endometrial cancer
por: Abdalla, Nabil, et al.
Publicado: (2017)

The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer
por: WEI, SU, et al.
Publicado: (2016)

HE4, CA-125, and cystic ovarian mass
por: Wiwanitkit, Viroj
Publicado: (2012)

Researches on the Correlation Between Estrogen and Progesterone Receptors Expression and Disease-Free Survival of Endometrial Cancer
por: Ren, Siling, et al.
Publicado: (2020)

The Preeminent Value of the Apparent Diffusion Coefficient in Assessing High-Risk Factors and Prognosis for Stage I Endometrial Carcinoma Patients
por: Quan, Quan, et al.
Publicado: (2022)

Assessment of levels of the tumor markers HE4 and CA125 considering staging, grading and histological types of endometrial cancer
por: Abdalla, Nabil, et al.
Publicado: (2016)

Preoperative serum CA125: a useful marker for surgical management of endometrial cancer
por: Jiang, Tao, et al.
Publicado: (2015)

Value of HE4 Combined with Cancer Antigen 125 in the Diagnosis of Endometrial Cancer
por: Dong, Chunhua, et al.
Publicado: (2017)

Utility of Pelvic MRI and Tumor Markers HE4 and CA125 to Predict Depth of Myometrial Invasion and Cervical Involvement in Endometrial Cancer
por: Zamani, Narges, et al.
Publicado: (2015)

Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer
por: Rong, Yan, et al.
Publicado: (2021)

Application value of Ki67 and serum CA125 in the deep myometrial invasion of endometrial adenocarcinoma
por: Qin, Lin
Publicado: (2023)

Menopausal Status Combined with Serum CA125 Level Significantly Predicted Concurrent Endometrial Cancer in Women Diagnosed with Atypical Endometrial Hyperplasia before Surgery †
por: Lou, Yaochen, et al.
Publicado: (2021)

Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women
por: Barr, Chloe E., et al.
Publicado: (2023)

The added value of CA125, HE4, and CA72-4 as markers for ovarian endometriosis diagnosis
por: Micu, Romeo, et al.
Publicado: (2023)

Exploring the Glycosylation of Serum CA125
por: Saldova, Radka, et al.
Publicado: (2013)

Correlation analysis and clinical significance of CA125, HE4, DDI, and FDP in type II epithelial ovarian cancer
por: Qiao, Li, et al.
Publicado: (2020)

Preoperative serum levels of HE4 and CA125 predict primary optimal cytoreduction in advanced epithelial ovarian cancer: a preliminary model study
por: Feng, Li-yuan, et al.
Publicado: (2020)

Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance
por: Brennan, Donal J, et al.
Publicado: (2015)

Meigs’ syndrome with elevated CA-125 and HE-4: a case of luteinized fibrothecoma
por: Danilos, Jaroslaw, et al.
Publicado: (2015)

Effect of Combination of Traditional Chinese Medicine with Western Medicine on Endometrial Carcinoma and Its Influence on Ultrasound, MRI, Tumor Markers HE4 and CA125
por: Gao, Xia, et al.
Publicado: (2021)

Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2018)

Standard and optimal cut-off values of serum ca-125, HE4 and ROMA in preoperative prediction of ovarian cancer in Vietnam
por: Huy, Nguyen Vu Quoc, et al.
Publicado: (2018)

A Clinical Diagnostic Value Analysis of Serum CA125, CA199, and HE4 in Women with Early Ovarian Cancer: Systematic Review and Meta-Analysis
por: Qing, Xiaolin, et al.
Publicado: (2022)

Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses
por: Terlikowska, Katarzyna M., et al.
Publicado: (2016)

The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer
por: Zheng, Li-e, et al.
Publicado: (2016)

Comparison of HE4, CA125, ROMA and CPH-I for Preoperative Assessment of Adnexal Tumors
por: Carreras-Dieguez, Núria, et al.
Publicado: (2022)

Are ROMA and HE4 More Accurate than CA-125, in Predicting of Ovarian Epithelial Carcinoma?
por: Behnamfar, Fariba, et al.
Publicado: (2023)

Retracted: A Clinical Diagnostic Value Analysis of Serum CA125, CA199, and HE4 in Women with Early Ovarian Cancer: Systematic Review and Meta-Analysis
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Determination of CA-125 levels in the serum, cervical and vaginal secretions, and endometrium in Chinese women with precancerous disease or endometrial cancer
por: He, Shu-Ming, et al.
Publicado: (2011)

Significance of mesothelin and CA125 expression in endometrial carcinoma: a retrospective analysis
por: Kakimoto, Soichiro, et al.
Publicado: (2021)

Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
por: Tuxen, M K, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_v63nkqje8umidbmo5285pvvc16